CPFF Board of Directors
Board Chair, Alberta
Kirk has come to know IPF through the experiences of his mother, Barbara Morrison of Niagara-on-the-Lake, who passed away from the disease in early 2020.
Kirk is a professional engineer with 40 years of experience in the energy & resources, environmental and infrastructure industries. He has Bachelors and Masters degrees in civil engineering from the Universities of Waterloo and British Columbia respectively, and is a graduate of the Directors Education Program from the Institute of Corporate Directors.
Mark Ashcroft, ONtario
Mark understands the challenges of living with pulmonary fibrosis. It took three years after the onset of symptoms for Mark to finally receive a diagnosis of IPF. He was already familiar with pulmonary fibrosis, having lost a brother to the disease in 1997, at the age of 41. Mark is currently waiting for a lung transplant.
Todd Georgieff, Quebec
“I am happy to be joining CPFF to help lead the organization through its next stage of growth. I have spent my whole career in healthcare, first as a hospital pharmacist and then managing global drug development programs for major pharma companies. I am hoping to apply some of that learning and experience to support patients, families, health providers and researchers working in this under-recognized disease area.”
Tom Hunter, Ontario
“It is so rewarding to be a part of CPFF. I lost my father to CPFF in 2016 and this is my way to honour his memory and help others affected by this disease.”
Tom Hunter is the Chief Executive Officer at Toronto Seniors Housing Corporation. Tom leads the collective efforts of staff and works with tenants and community partners to shape the strategy and future of Toronto Seniors Housing.
Ranjena Maloni, Ontario
Ranjena Maloni joined the board in 2017 after a second member of her family was diagnosed with idiopathic pulmonary fibrosis. She is a clinical research management professional with more than 10 years experience in academic research programs. She is currently the manager of a large national oncology research network.
Moyra Martin, Alberta
“My husband Dick passed away from pulmonary fibrosis in 2018 after a twelve-year battle with this disease. I believe that to affect change, one must be involved. I am honoured to be a Director with the Canadian Pulmonary Fibrosis Foundation and to have opportunities to use my leadership skills to move forward actions that impact patients and all those affected by pulmonary fibrosis.
Verity Pringle, Treasurer, British Columbia
Verity is a Chartered Professional Accountant working as an Assurance Manager with BDO Canada. Through her work, she assists many charitable and not-for-profit organizations with financial reporting in accordance with accounting standards for not-for-profit organizations.
Ray Protti, British Columbia
A University of Alberta graduate with an MA in economics, Ray Protti was President and CEO of the Canadian Bankers Association from 1996 to 2007. Prior to that he spent more than 25 years in the federal public service in Ottawa, where his positions included Deputy Minister of Labour, Director of the Canadian Security Intelligence Service and Deputy Minister of Agriculture and Agri-Food Canada.
Holly Smith, British Columbia
“As an oppressed minority, I understand how challenging it is to deal with a life-limiting illness while at the same time experiencing fear of accessing needed resources. I would bring to the board this understanding and acknowledgement and can help to support others who are in similar positions.”
Dr. Gokul Vidyasankar, Newfoundland & Labrador
Dr. Gokul Vidyasankar is a respirologist and associate professor of medicine at Memorial University in St. John’s, Newfoundland. Dr. Vidyasankar grew up in St. John’s and has always considered Newfoundland his home. He joined Memorial University in 2014, and has been happy to be a part of their robust and diverse faculty.
Ex officio, Sharon Lee, Executive Director
“I am honoured to use my fundraising experience and leadership skills to expand CPFF’s services for Canadians living with pulmonary fibrosis and to continue to invest in research for advances in treatments and a cure.”